Search research articles
Contact Us
Filters
Showing results (131-140 of 279) with videos related to
Page
of 28
Sort By:
Haematologica
|
February 18, 2017
Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols
Marius Rohde, Bettina R Bonn, Martin Zimmermann, et al.
Leukemia
|
February 27, 2024
Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia-a case-control study
Stefanie V Junk, Alisa Förster, Gunnar Schmidt, et al.
Leukemia
|
July 5, 2022
Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia
Paula Möker, Udo Zur Stadt, Martin Zimmermann, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
February 17, 2021
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data
Gudrun Würthwein, Claudia Lanvers-Kaminsky, Christian Siebel, et al.
British Journal of Haematology
|
September 20, 2011
Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey
Klaus Bienemann, Birgit Burkhardt, Simon Modlich, et al.
Haematologica
|
April 18, 2020
Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group
Olga Moser, Martin Zimmermann, Ulrike Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2020
Stem Cell Transplantation and Vinblastine Monotherapy for Relapsed Pediatric Anaplastic Large Cell Lymphoma: Results of the International, Prospective ALCL-Relapse Trial
Fabian Knörr, Laurence Brugières, Marta Pillon, et al.
Leukemia
|
March 24, 2020
Leukemia-induced dysfunctional TIM-3<sup>+</sup>CD4<sup>+</sup> bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients
Franziska Blaeschke, Semjon Willier, Dana Stenger, et al.
Haematologica
|
August 5, 2021
Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group
Gabriele Escherich, Udo Zur Stadt, Arndt Borkhardt, et al.
Blood
|
April 10, 2010
Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol
Gunnar Cario, Martin Zimmermann, Renja Romey, et al.
Page
of 28
Search research articles
Search
Showing results (131-140 of 279) with videos related to
Sort By:
Page
of 28
Haematologica
|
February 18, 2017
Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols
Marius Rohde, Bettina R Bonn, Martin Zimmermann, et al.
Leukemia
|
February 27, 2024
Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia-a case-control study
Stefanie V Junk, Alisa Förster, Gunnar Schmidt, et al.
Leukemia
|
July 5, 2022
Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia
Paula Möker, Udo Zur Stadt, Martin Zimmermann, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
February 17, 2021
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data
Gudrun Würthwein, Claudia Lanvers-Kaminsky, Christian Siebel, et al.
British Journal of Haematology
|
September 20, 2011
Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey
Klaus Bienemann, Birgit Burkhardt, Simon Modlich, et al.
Haematologica
|
April 18, 2020
Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group
Olga Moser, Martin Zimmermann, Ulrike Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2020
Stem Cell Transplantation and Vinblastine Monotherapy for Relapsed Pediatric Anaplastic Large Cell Lymphoma: Results of the International, Prospective ALCL-Relapse Trial
Fabian Knörr, Laurence Brugières, Marta Pillon, et al.
Leukemia
|
March 24, 2020
Leukemia-induced dysfunctional TIM-3<sup>+</sup>CD4<sup>+</sup> bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients
Franziska Blaeschke, Semjon Willier, Dana Stenger, et al.
Haematologica
|
August 5, 2021
Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group
Gabriele Escherich, Udo Zur Stadt, Arndt Borkhardt, et al.
Blood
|
April 10, 2010
Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol
Gunnar Cario, Martin Zimmermann, Renja Romey, et al.
Page
of 28